Pediatr. praxi. 2010;11(6):358-362

Pertussis - still topical problem not only in children

MUDr.Zuzana Blechová
Infekční klinika, FN Na Bulovce, Praha

Nárůst incidence pertuse navzdory očkování představuje epidemiologický, diagnostický a terapeutický problém. Nejčastěji je infekce

hlášena u dětí mezi 10.–14. rokem života. U adolescentů a dospělých s mírným či atypickým průběhem pertuse uniká pozornosti, nebývá

diagnostikována, tudíž ani hlášena. Tito mohou být zdrojem infekce pro vnímavé kojence, mnohdy i sami asymptomatičtí. Změna

vyhlášky o očkování s posunem první dávky hexavakcíny do 9. týdne života a přeočkování proti pertusi v 10. roce života jsou důležitým,

avšak pouze dílčím preventivním opatřením. Přeočkování dospělé populace proti pertusi je rovněž žádoucí minimálně jedenkrát za život,

ideálně každých deset let. Vhodné se jeví uplatnění tzv. rodinné strategie (z angl. „cocoon strategy“) při očkování rodičů a blízkých

kontaktů vnímavých kojenců včetně doporučení vakcinace vybraných zdravotníků.

Keywords: pertussis, Bordetella pertussis, vaccination, acellular pertussis vaccine, cocoon strategy, vaccination shedule

Published: December 9, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Blechová Z. Pertussis - still topical problem not only in children. Pediatr. praxi. 2010;11(6):358-362.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Pertussis vaccines: WHO position paper. Wkly Epidemiol Rec. 2010; 1, 85(40): 385-400. Go to PubMed...
    2. Winter K, Harriman K, Schechter R, et al. Notes from the Field: Pertussis - California, January-June 2010, Morbidity and Mortality Weekly Report (MMWR), 2010; 59(26): 817.
    3. Van Boven MN, et al. Unveiling the burden of pertussis. Trends Microbiol 2004; (12)3: 116-119. Go to original source... Go to PubMed...
    4. Fabiánová K, Beneš Č, Kříž B. A Steady Rise in Incidence of Pertussis Since Nineties in the Czech Republic. Epidemiol. Mikrobiol. Imunol. 2010; (59)1: 25-33.
    5. Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev. 2005; 18(2): 326-382. Go to original source... Go to PubMed...
    6. Blechová Z. Pertuse - opomíjená infekce. Pediatr. pro Praxi 2008; 9(4): 223-226.
    7. Shakib JH, Wyman L, Gesteland PH, et al. Should the Pertussis Case Definition for Public Health Reporting Be Refined? J Public Health Management Practice 2009; 15(6): 479-484. Go to original source... Go to PubMed...
    8. Cornia PB, Hersh AL, Lipsky BA, et al. Does this coughing adolescent or adult patient have pertussis? JAMA 2010; 25, 304(8): 890-896. Go to original source... Go to PubMed...
    9. Irwin RS. Complications of cough: ACCP evidence-based clinical practice guidelines. Chest 2006; 129(Suppl. 1): 54S-58S. Go to original source... Go to PubMed...
    10. Mooi FR, van Loo IHM, van Gent M, et al. Bordetella pertussis strains with Increased Production Toxin asssociated with Bordetella Resurgance. Emerging Inf Diseases 2009; (15)8: 1206-1213. Go to original source... Go to PubMed...
    11. Wendelboe AM, et al. Estimating the role of casual contact from the community in transmission of Bordetella pertussis to young infants. Emerging Themes in Epidemiology, 2007; 4: 15. Go to original source... Go to PubMed...
    12. Greeff SC. Pertussis Disease Burden in the Household: How to Protect Young Infants. Clinical Infectious Diseases 2010; 50(10): 1339-1345. Go to original source... Go to PubMed...
    13. Bettiol S, Thompson MJ, Roberts NW, et al. Symptomatic treatment of the cough in whooping cough. Cochrane Database Syst Rev. 2010; 20(1): CD003257. Go to original source... Go to PubMed...
    14. Chang AB, Winter D, Acworth JP. Leukotriene receptor antagonist for prolonged non-specific cough in children. Cochrane Database Syst Rev. 2006; 19(2): CD005602. Go to original source... Go to PubMed...
    15. Nakamura Y, et al. Marked difference between adults and children in Bordetella pertussis DNA load in nasopharyngeal swabs. Clin Microbiol Infect, 2010.
    16. Bidet P, et al. Real-time PCR measurement of persistence of Bordetella pertussis DNA in nasopharyngeal secretions during antibiotic treatment of young children with pertussis. J Clin Microbiol. 2008; 46(11): 3636-3638. Go to original source... Go to PubMed...
    17. Wright SW, et al. Pertussis infection in adults with persistent cough. Journal of the American Medical Association 1995; 273: 1044-1046. Go to original source... Go to PubMed...
    18. Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J. 2005; 24(Suppl. 5): S58-61. Go to original source... Go to PubMed...
    19. Healy CM, Munoz FM, Rench MA, et al. Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum. J Infect Dis. 2004; 15, 190(2): 335-340. Go to original source... Go to PubMed...
    20. Bonhoeffer J, Bär G, Riffelmann M, et al. The role of Bordetella infections in patients with acute exacerbation of chronic bronchitis. Infection 2005; 33(1): 13-17. Go to original source... Go to PubMed...
    21. Van Rie A, Hethcote HW. Adolescent and adult pertussis vaccination: computer simulations of five new strategies. Vaccine 2004; 13; 22(23-24): 3154-3165. Go to original source... Go to PubMed...

    Return to the content


    Pediatrics for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.